Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Innoviva Inc (INVA)

Innoviva Inc (INVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,409,349
  • Shares Outstanding, K 101,392
  • Annual Sales, $ 261,020 K
  • Annual Income, $ 157,290 K
  • 60-Month Beta 1.03
  • Price/Sales 5.28
  • Price/Cash Flow 7.80
  • Price/Book 2.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.42
  • Number of Estimates 1
  • High Estimate 0.42
  • Low Estimate 0.42
  • Prior Year 0.36
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.12 +4.80%
on 07/24/20
14.64 -6.08%
on 07/20/20
+0.30 (+2.31%)
since 07/13/20
3-Month
12.76 +7.76%
on 06/15/20
15.62 -11.97%
on 06/23/20
+0.44 (+3.38%)
since 05/13/20
52-Week
7.58 +81.40%
on 03/19/20
15.62 -11.97%
on 06/23/20
+2.37 (+20.93%)
since 08/13/19

Most Recent Stories

More News
Innoviva: 2Q Earnings Snapshot

BURLINGAME, Calif. (AP) _ Innoviva Inc. (INVA) on Wednesday reported second-quarter earnings of $76.8 million.

INVA : 13.73 (-1.22%)
Innoviva Reports Second Quarter 2020 Financial Results

Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the second quarter ended June 30, 2020.

INVA : 13.73 (-1.22%)
Innoviva (INVA) to Report Q2 Earnings: What's in the Cards?

During Innoviva's (INVA) upcoming Q2 earnings call, investor focus will be on the royalties earned that comprise the company's top line.

GSK : 41.25 (-2.16%)
AGEN : 3.81 (+7.02%)
ACAD : 40.01 (+0.38%)
INVA : 13.73 (-1.22%)
Has Innoviva (INVA) Outpaced Other Medical Stocks This Year?

Is (INVA) Outperforming Other Medical Stocks This Year?

INVA : 13.73 (-1.22%)
Innoviva (INVA) Looks Good: Stock Adds 8.9% in Session

Innoviva (INVA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

LLY : 150.69 (-1.22%)
INVA : 13.73 (-1.22%)
Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) ("Entasis"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the closing...

ETTX : 2.94 (+1.03%)
INVA : 13.73 (-1.22%)
AbbVie (ABBV) Hits 52-Week High, Can the Run Continue?

AbbVie (ABBV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ABBV : 94.95 (-0.59%)
BMY : 63.55 (-0.14%)
BAYRY : 16.9800 (-0.35%)
INVA : 13.73 (-1.22%)
Innoviva (INVA) Stock Moves -0.77%: What You Should Know

Innoviva (INVA) closed at $14.13 in the latest trading session, marking a -0.77% move from the prior day.

INVA : 13.73 (-1.22%)
Are Investors Undervaluing Innoviva (INVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

INVA : 13.73 (-1.22%)
Innoviva (INVA) Gains But Lags Market: What You Should Know

Innoviva (INVA) closed the most recent trading day at $13.92, moving +0.43% from the previous trading session.

INVA : 13.73 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INVA with:

Business Summary

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance,...

See More

Key Turning Points

2nd Resistance Point 14.40
1st Resistance Point 14.15
Last Price 13.73
1st Support Level 13.68
2nd Support Level 13.46

See More

52-Week High 15.62
Last Price 13.73
Fibonacci 61.8% 12.55
Fibonacci 50% 11.60
Fibonacci 38.2% 10.65
52-Week Low 7.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar